Antinuclear antibody (ANA) positivity was found in 75.00% of CTD‐ITP patients, while extractable nuclear antigen (ENA) antibodies were present in nearly 80.21% of patients. The gene discussed is BTG3; the disease is autoimmune thrombocytopenic purpura.